PMDA drug package insert
ランツジールコーワ錠30mg
PMDA Prescription drug · 興和株式会社 · package insert Feb 2, 2026
Key facts
| Brand names | ランツジールコーワ錠30mg |
|---|---|
| Nonproprietary names | アセメタシン |
| Companies | 製造販売元／興和株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 非ステロイド性抗炎症・鎮痛・解熱剤 |
| Therapeutic category codes | 871145 |
| YJ codes | 1145003F1030 |
| Approval numbers | 22000AMX01558 |
| Package insert edition | 第3版 |
| Package insert date | Feb 2, 2026 |
| PMDA document key | 270072_1145003F1030_1 |
| PMDA company code | 270072 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: